INTCO MEDICAL(SZ:300677)2025-05-15 09:54Group 1: Share Buyback and Dividend Distribution - The company has repurchased a total of 21,030,307 shares as of April 30, 2025, with a total transaction amount of RMB 467,953,973.43 (excluding transaction fees) [2][4] - In 2024, the company distributed cash dividends amounting to RMB 32,068,908.15 (including tax) [4] - The proposed total cash dividend for 2024 is approximately RMB 63,916,500 (including tax), which represents 18.40% of the net profit attributable to shareholders [5] Group 2: Market Management and Strategy - The company is actively enhancing market competitiveness by expanding both domestic and international markets, optimizing business layout, and increasing market share [3] - The company has implemented a market diversification strategy, reducing the proportion of revenue from the U.S. market, which currently accounts for approximately 30%-35% of overseas revenue [3] - The current tariffs for medical-grade nitrile gloves exported to the U.S. are 80%, while industrial-grade nitrile gloves are subject to a 55% tariff, and PVC gloves face a 30% tariff [3] Group 3: Share Buyback Progress - As of April 30, 2025, the company has repurchased 2,523,900 shares, representing 0.3906% of the total share capital of 646,204,669 shares [5] - The highest and lowest transaction prices for the repurchased shares were RMB 23.89 and RMB 20.06 per share, respectively, with a total transaction amount of RMB 53,518,589.28 (excluding transaction fees) [5]